Cargando…
Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities
The approval process for pharmaceuticals has always included a consideration of the trade-offs between benefits and risks. Until recently, these trade-offs have been made in panel discussions without using a decision model to explicitly consider what these trade-offs might be. Recently, the EMA and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790083/ https://www.ncbi.nlm.nih.gov/pubmed/35096913 http://dx.doi.org/10.3389/fmed.2021.820335 |